Pharmaceutical Investing Medexus Holds Annual Meeting of Shareholders and Announces Election of Directors
Pharmaceutical Investing Medexus Announces Fiscal Q1 2026 Results, Including Positive Results from US Launch of GRAFAPEX for Injection
Standard Uranium Announces Expansion of Davidson River Drill Program and Provides Update on Private Placement and LIFE Offering
